Arboretum_JD, Author at Arboretum Ventures

Allay Therapeutics Completes Oversubscribed $60M Financing Led by Arboretum Ventures

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…

Arboretum_JDSeptember 15, 2021

Koya Medical News Page

Koya Medical and Essity Sponsor Forum for Physicians, Lymphedema Therapists and Researchers to Discuss Health Effects of Space Travel

Koya Medical, a transformative healthcare company focused on developing breakthrough treatments for lymphedema and venous…

Arboretum_JDSeptember 15, 2021

Francis Medical Home Page News Page

Francis Medical Announces Close of $55 Million Series B Equity Financing

Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor…

Arboretum_JDSeptember 15, 2021

Home Page News Page RareCyte

RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform

RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms…

Arboretum_JDSeptember 9, 2021

Arboretum News Page

Capital Allocators Podcast: Jan Garfinkle is Interviewed by Roz Hewsenian of The Helmlsey Charitable Trust Foundation

On today’s show, Roz Hewsenian interviews Jan Garfinkle. Roz serves as the Chief Investment Officer…

Arboretum_JDSeptember 7, 2021

News Page Strata Oncology

New Publication in JCO Precision Oncology Demonstrates the Ability of StrataNGS®

Study shows StrataNGS substantially increases patient access to tissue-based comprehensive genomic profiling.

Arboretum_JDAugust 23, 2021

Cardiac Dimensions News Page

Cardiac Dimensions® Announces Launch of Their Optimized U.S. Pivotal Trial – The EMPOWER Trial

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address…

Arboretum_JDAugust 20, 2021

Arboretum Home Page News Page

Arboretum Ventures Promotes Dan Kidle to Managing Partner

Arboretum Ventures, a leading healthcare venture capital firm based in Ann Arbor, Michigan, today announced…

Arboretum_JDAugust 11, 2021

News Page Pear Therapeutics

Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRX

Pear Therapeutics, Inc. today announced formulary availability of its commercial products at OptumRx, Inc., the…

Arboretum_JDAugust 10, 2021

Koya Medical News Page

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases…

Arboretum_JDAugust 10, 2021

Arboretum_JD

Allay Therapeutics Completes Oversubscribed $60M Financing Led by Arboretum Ventures

Koya Medical and Essity Sponsor Forum for Physicians, Lymphedema Therapists and Researchers to Discuss Health Effects of Space Travel

Francis Medical Announces Close of $55 Million Series B Equity Financing

RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform

Capital Allocators Podcast: Jan Garfinkle is Interviewed by Roz Hewsenian of The Helmlsey Charitable Trust Foundation

New Publication in JCO Precision Oncology Demonstrates the Ability of StrataNGS®

Cardiac Dimensions® Announces Launch of Their Optimized U.S. Pivotal Trial – The EMPOWER Trial

Arboretum Ventures Promotes Dan Kidle to Managing Partner

Pear Therapeutics Announces Formulary Availability for its Three FDA Authorized Prescription Digital Therapeutics at OptumRX

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

News & Insights

ARCHIVES